Non-Executive Chairman
Dr David Brown has over 30 years experience in the pharmaceutical / biotechnology industry both in research and in senior executive roles. He served with 4 of the top 10 pharmaceutical companies: Zeneca, Pfizer, GlaxoWellcome, and Hoffman La-Roche; and also as President and Chief Executive of Cellzome AG, a biotechnology company with headquarters in Heidelberg, Germany.
Whilst at Pfizer he was named co-inventor on the patent for Viagra, a treatment for male impotence, and he led the team that developed Viagra through to proof of clinical efficacy in human clinical trials. The drug is also marketed for treatment of Pulmonary Hypertension under the trade name Revatio.
He also had a pivotal role in the discovery of Relpax, a treatment for migraine. While at Roche in Switzerland, he was a Director of the company and had responsibility over staff focused on drug discovery at all six of Roche’s research sites in the USA, Europe and Asia. He served on Clinical Development and Business Development senior committees.